新辅助免疫疗法在胃食道癌症中的演变格局
Colum Dennehy1, Alisha F Khan2, Ali H Zaidi2
1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
免疫疗法改善了食道胃癌 (EGC) 患者的生存率. 新辅助和外科手术期间的免疫疗法显示出希望,但最佳使用和患者选择需要进一步研究以获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 胃肠道癌症研究研究
背景情况:
- 消化管胃癌 (EGC) 治疗进展仍然面临着改善患者生存率的挑战.
- 辅助免疫疗法现在是切除EGC的标准,表明改善了无复发生存率.
- 新辅助和外科手术期间的免疫疗法比辅助疗法具有潜在的优势.
研究的目的:
- 审查目前对可切除EGC的护理标准.
- 讨论EGC中免疫检查点抑制剂的理由和证据.
- 检查免疫疗法在EGC治疗中的未来作用,挑战和机会.
主要方法:
- 对EGC的新辅助和外科期间的免疫疗法进行临床前和早期临床数据的审查.
- 对当前治疗模式和新兴免疫疗法策略的分析.
- 讨论挑战,包括最佳时间,持续时间和组合疗法.
主要成果:
- 辅助免疫疗法在改善切除EGC.的无复发生存率方面表现出有效性.
- 早期研究表明,新辅助和外科手术期间的免疫疗法是有希望的,但需要进一步调查.
- 确定用于患者选择和响应预测的生物标志物对于最大化益处至关重要.
结论:
- 免疫疗法具有显著的潜力,可以提高EGC患者的治疗结果.
- 需要进一步的研究来优化新辅助/外科手术免疫疗法方案和患者选择.
- 解决时间,剂量,组合和生物标志物发现方面的挑战是推动EGC免疫疗法的关键.
更多相关视频
10:42Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion
Published on: July 6, 2022
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
相关概念视频
Tumor Immunotherapy
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
